Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 3774 - Provider product page
- Provider
- Cell Signaling Technology, Inc
- Proper citation
- Cell Signaling Technology Cat#3774, RRID:AB_390750
- Product name
- Phospho-Jak2 (Tyr221) Antibody
- Antibody type
- Polyclonal
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Storage
- -20°C
Submitted references Thrombopoietin/MPL participates in initiating and maintaining RUNX1-ETO acute myeloid leukemia via PI3K/AKT signaling.
Hepatocyte growth factor suppresses the anticancer effect of irinotecan by decreasing the level of active metabolite in HepG2 cells.
Pulikkan JA, Madera D, Xue L, Bradley P, Landrette SF, Kuo YH, Abbas S, Zhu LJ, Valk P, Castilla LH
Blood 2012 Jul 26;120(4):868-79
Blood 2012 Jul 26;120(4):868-79
Hepatocyte growth factor suppresses the anticancer effect of irinotecan by decreasing the level of active metabolite in HepG2 cells.
Okumura M, Iwakiri T, Takagi A, Hirabara Y, Kawano Y, Arimori K
Biochemical pharmacology 2011 Dec 1;82(11):1720-30
Biochemical pharmacology 2011 Dec 1;82(11):1720-30
No comments: Submit comment
No validations: Submit validation data